Aadi Bioscience (AADI)
(Delayed Data from NSDQ)
$2.11 USD
-0.04 (-1.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $2.10 -0.01 (-0.47%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Aadi Bioscience, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -65.77 | -60.51 | -110.09 | -4.32 | -23.27 |
Depreciation/Amortization & Depletion | -2.97 | 2.67 | 74.26 | 0.06 | 0.08 |
Net Change from Assets/Liabilities | -3.40 | -1.82 | 12.25 | -2.48 | -1.89 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 12.47 | 10.03 | 1.16 | 1.35 | 1.23 |
Net Cash From Operating Activities | -59.66 | -49.64 | -22.42 | -5.38 | -23.85 |
Property & Equipment | -3.97 | -0.44 | -0.05 | -0.02 | -0.24 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 29.70 | 0.00 | 0.00 |
Investments | 87.18 | -132.44 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -4.50 | 0.00 | 0.00 |
Net Cash from Investing Activities | 83.21 | -132.89 | 25.15 | -0.02 | -0.24 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.49 | 73.28 | 155.83 | 9.89 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | -4.41 | 0.00 | 0.00 |
Other Financing Activities | -0.16 | -0.66 | -9.62 | -0.40 | 0.00 |
Net Cash from Financing Activities | 0.33 | 72.62 | 141.80 | 9.48 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 23.87 | -109.91 | 144.53 | 4.08 | -24.09 |
Cash at Beginning of Period | 39.08 | 148.99 | 4.46 | 38.52 | 62.61 |
Cash at End of Period | 62.95 | 39.08 | 148.99 | 42.60 | 38.52 |
Diluted Net EPS | -2.44 | -2.69 | -12.41 | -1.50 | -8.55 |
Fiscal Year End for Aadi Bioscience, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -32.87 | -18.29 | -65.77 | -49.50 |
Depreciation/Amortization & Depletion | NA | -0.71 | -0.37 | -2.97 | -2.53 |
Net Change from Assets/Liabilities | NA | -1.94 | -4.75 | -3.40 | -7.25 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 6.72 | 3.76 | 12.47 | 9.25 |
Net Cash From Operating Activities | NA | -28.81 | -19.65 | -59.66 | -50.02 |
Property & Equipment | NA | -1.28 | -0.74 | -3.97 | -3.16 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 8.26 | 11.29 | 87.18 | 82.71 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 6.98 | 10.56 | 83.21 | 79.56 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.09 | 0.01 | 0.49 | 0.37 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.02 | -0.01 | -0.16 | -0.13 |
Net Cash from Financing Activities | NA | 0.08 | -0.01 | 0.33 | 0.25 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -21.75 | -9.11 | 23.87 | 29.78 |
Cash at Beginning of Period | NA | 62.95 | 62.95 | 39.08 | 39.08 |
Cash at End of Period | NA | 41.20 | 53.84 | 62.95 | 68.87 |
Diluted Net EPS | NA | -0.54 | -0.68 | -0.60 | -0.60 |